---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-046170"
form_type: "8-K"
ticker: "TOVX"
cik: "0000894158"
company_name: "Theriva Biologics, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T06:21:59.615364+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Theriva Biologics closes $7.5M public offering of common stock and warrants

## Summary
- Gross proceeds of ~$7.5M from offering of 6.8M shares (or pre-funded warrants) and common warrants at $1.10/unit.
- Offering includes 1.99M shares, 4.83M pre-funded warrants, and 6.82M common warrants exercisable at $1.10 for 5 years.
- Proceeds primarily for working capital, R&D, and manufacturing scale-up; no acquisition commitments.
- Post-closing shares outstanding: 4,773,358 (excluding warrants).
- A.G.P./Alliance Global Partners acted as placement agent.

## SEC filing metadata
- accession: 0001104659-25-046170
- form_type: 8-K
- ticker: TOVX
- cik: 0000894158
- company_name: Theriva Biologics, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/894158/000110465925046170/0001104659-25-046170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/894158/000110465925046170/tm2514447d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-046170
- JSON: https://secwatch.observer/filing/0001104659-25-046170.json
- Plain text: https://secwatch.observer/filing/0001104659-25-046170.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.